Accessibility Menu
 
InVitro International logo

InVitro International

(OTC) IVRO

Current Price$0.09
Market Cap$1.97M
Since IPO (1992)-97%
5 Year-7%
1 Year+10%
1 Month+0%

InVitro International Financials at a Glance

Market Cap

$1.97M

Revenue (TTM)

$817.39K

Net Income (TTM)

$98.73K

EPS (TTM)

$0.00

P/E Ratio

20.70

Dividend

$0.00

Beta (Volatility)

0.02 (Low)

Price

$0.09

Volume

15

Open

$0.06

Previous Close

$0.09

Daily Range

$0.06 - $0.09

52-Week Range

$0.06 - $0.16

IVRO News

No articles available.

IVRO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InVitro International

Industry

Healthcare Equipment and Supplies

Employees

5

CEO

W. Richard Ulmer

Headquarters

Placentia, CA 92870, US

IVRO Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

8%

Net Income Margin

12%

Return on Equity

6%

Return on Capital

3%

Return on Assets

5%

Earnings Yield

4.83%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.97M

Shares Outstanding

22.16M

Volume

15

Short Interest

0.00%

Avg. Volume

28.79K

Financials (TTM)

Gross Profit

$718.09K

Operating Income

$87.02K

EBITDA

$129.44K

Operating Cash Flow

$7.28K

Capital Expenditure

$1.40K

Free Cash Flow

$8.68K

Cash & ST Invst.

$1.22M

Total Debt

$287.18K

InVitro International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$182.60K

-25.2%

Gross Profit

$150.52K

-24.7%

Gross Margin

82.43%

N/A

Market Cap

$1.97M

N/A

Market Cap/Employee

$328.70K

N/A

Employees

6

N/A

Net Income

$10.60K

-68.7%

EBITDA

$5.50K

-84.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$753.71K

-19.7%

Accounts Receivable

$50.73K

-25.5%

Inventory

$180.08K

+0.5%

Long Term Debt

$412.71K

+51.9%

Short Term Debt

$65.37K

+17.8%

Return on Assets

4.97%

N/A

Return on Invested Capital

3.50%

N/A

Free Cash Flow

$8.36K

+245.9%

Operating Cash Flow

$8.36K

+245.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SHMNSOHM, Inc.
$0.00+10.00%
YBGJYubo International Biotech Limited
$0.01-31.13%
PLSHPanacea Life Sciences Holdings, Inc.
$0.05+11.11%
MITIMitesco, Inc.
$0.10-8.84%

Trending Stocks

Symbol / CompanyPricePrice Chg
UGROUrban-gro
$6.15+1.82%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.57+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.95+0.07%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.58-0.03%

Questions About IVRO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.